William Roberts - VP Reg Dev & Med Safety, Regeneron Pharmaceuticals Inc

As of September 20, 2013


William Roberts Net Worth

  • Net worth is estimated to be at least $16.42M
  • Owns at least 14,647 units of Regeneron Pharmaceuticals Inc stock
  • Sold an estimated value of $19.34M in the last 10 years at Regeneron Pharmaceuticals Inc

William Roberts Trading

  • Largest purchase of shares was 60,000 units , worth over $1.27M on January 11, 2012
  • Largest sale of shares was 23,000 units , worth over $4.56M on September 20, 2013
  • In total has made about 31 transactions over 10 years
  • Usually trades in December, with the busiest year in 2011
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Regeneron Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

Regeneron Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 11,948 units sold on September 17, 2021 by N. Anthony Coles worth over $7.87M
  • In the last 18 years, insiders at Regeneron Pharmaceuticals Inc sold an estimated value of $16.57B and bought an estimated value of $3.09B
  • The most active traders are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director
  • Insider trading is most common in December, with the busiest year in 2014

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1